|
|
|||||||||
Clinical Investigations |
1 Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
2 Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
3 The Community/Academia Coalition, Mountain View, California
4 Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts
5 Division of Nuclear Medicine, Stanford University School of Medicine, Palo Alto, California
Methylphenidate (MPH) is an effective symptomatic treatment of attention deficit hyperactivity disorder (ADHD), but the mechanisms of its therapeutic action have not been fully elucidated. To address this issue, we assessed the effects of discontinuation of chronic MPH treatment on regional cerebral blood flow (rCBF) in ADHD patients. Methods: Twenty-two prepubescent boys with ADHD (age range, 8.211.5 y) and 7 healthy volunteers were studied with SPECT on and off MPH. Their rCBF data were automatically normalized to whole-brain counts and coregistered with standard anatomic space. rCBF changes were evaluated with statistical parametric mapping based on voxel-by-voxel ANOVA. Results: When the subjects were not taking MPH, rCBF was higher in the motor, premotor, and the anterior cingulate cortices (Brodmanns areas 4, 6, and 32). Conclusion: Brief discontinuation of MPH treatment is associated with increased motor and anterior cingulate cortical activity. Our findings suggest that MPH treatment modulates motor and anterior cingulate cortical activity directly or indirectly. Alternatively, our findings may be related to MPH withdrawal. These data provide novel information on the potential mechanisms of the therapeutic action of MPH. Furthermore, they are clinically relevant to the commonly occurring brief interruptions in MPH treatment.
Key Words: methylphenidate statistical parametric mapping SPECT attention deficit hyperactivity disorder motor cortex anterior cingulate cortex
This article has been cited by other articles:
![]() |
G. Bush, T. J. Spencer, J. Holmes, L. M. Shin, E. M. Valera, L. J. Seidman, N. Makris, C. Surman, M. Aleardi, E. Mick, et al. Functional Magnetic Resonance Imaging of Methylphenidate and Placebo in Attention-Deficit/Hyperactivity Disorder During the Multi-Source Interference Task Arch Gen Psychiatry, January 1, 2008; 65(1): 102 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Pliszka, D. C. Glahn, M. Semrud-Clikeman, C. Franklin, R. Perez III, J. Xiong, and M. Liotti, Neuroimaging of Inhibitory Control Areas in Children With Attention Deficit Hyperactivity Disorder Who Were Treatment Naive or in Long-Term Treatment Am J Psychiatry, June 1, 2006; 163(6): 1052 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shaw, J. Lerch, D. Greenstein, W. Sharp, L. Clasen, A. Evans, J. Giedd, F. X. Castellanos, and J. Rapoport Longitudinal Mapping of Cortical Thickness and Clinical Outcome in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry, May 1, 2006; 63(5): 540 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. X. Castellanos Proceed, with Caution: SPECT Cerebral Blood Flow Studies of Children and Adolescents with Attention Deficit Hyperactivity Disorder J. Nucl. Med., December 1, 2002; 43(12): 1630 - 1633. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |